| Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer (NCT07684456) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2026-08-01 |
| Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT07044349) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2025-09-01 |
| Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06841679) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2025-08-28 |
| Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases (NCT06683703) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2024-12-01 |
| Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors (NCT06730581) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2024-12-01 |
| Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors (NCT05700084) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2023-06-09 |
| Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer (NCT05673629) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2023-05-30 |
| Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT05673590) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2023-05-12 |
| Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors (NCT04911907) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2021-01-22 |
| PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer (NCT05052437) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2020-10-15 |
| Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） (NCT03693547) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2019-04-22 |
| Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer (NCT03906565) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2019-04-12 |